USP16 and inflammatory bowel disease: When stimulated by LPS or TNF-α, USP16 specifically removes Lys33-linked IKKs polyubiquitin chains and promotes IKK-β-mediated phosphorylation of P105, leading to autoimmune responses and the development of IBD (215).